Thalidomide - Celgene Corporation
At a glance
- Drug Originator EntreMed; National Cancer Institute (USA); National Institute of Allergy and Infectious Diseases; National Institutes of Health (USA); University of Pennsylvania
- Drug Licenced by Celgene Corporation; Erkim; Fujimoto Pharmaceutical; Menarini Asia-Pacific; Neopharm Ltd
- Drug Class Antifibrotics; Antileprotics; Antineoplastics; Antitussives; Indoles; Phthalimides; Piperidones; Small molecules
- Mechanism of Action Angiogenesis inhibitors; Immunosuppressants; Tumour necrosis factor inhibitors
- USA Patent Applicants BRISTOL-MYERS
- USA Patents 20
- NDAs 1
- Patent Applications 4,471
Table of Contents

Disclaimer